HRTS — Tema Heart & Health ETF
Data updated: 2026-07-29
HRTS — Tema Heart & Health ETF data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $51.92M AUM · 0.75% expense ratio · 26.3% 1-yr return. From SEC regulatory filings.
HRTS Fund Overview
HRTS — Tema Heart & Health ETF is a US ETF managed by Tema ETF Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Tema ETF Trust
- Category: United States Health Care Equity
- Assets under management: $51.92M
- 1-year return: 26.3%
- Ticker: HRTS
- SEC CIK: 0001944285
- SEC series ID: S000081541
- Share class ID: C000244455
HRTS Holdings
Top 10 holdings of Tema Heart & Health ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly & Co | 11.52% |
| UnitedHealth Group Inc | 5.24% |
| Novo Nordisk A/S | 5.24% |
| Roche Holding AG | 4.50% |
| Merck & Co Inc | 4.27% |
| AstraZeneca PLC | 4.00% |
| Thermo Fisher Scientific Inc | 3.97% |
| Johnson & Johnson | 3.59% |
| Gilead Sciences Inc | 3.43% |
| Novartis AG | 3.38% |
HRTS Portfolio Allocation
Asset-class allocation of Tema Heart & Health ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.2% |
| Cash & Equivalents | 0.7% |
HRTS Performance
Total returns for HRTS (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -2.7% |
| 1 year | 26.3% |
| 3 years (annualised) | 11.1% |
HRTS Risk Information
Risk metrics for HRTS, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.2%
HRTS Costs and Fees
HRTS costs about $75 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.75%
- Gross expense ratio: 0.99%
- Portfolio turnover: 40%
- Brokerage commissions: 2.54 bps of average net assets (SEC N-CEN)
HRTS Cashflows
Over the 12 months to 2026-02, Tema Heart & Health ETF had net outflows of $18.06M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-02 | −$2.13M |
| 2026-01 | $1.43M |
| 2025-12 | $2.82M |
| 2025-11 | −$2.62M |
| 2025-10 | −$1.61M |
| 2025-09 | −$2.51M |
HRTS Debt Constituents
No individual debt constituents are reported in Tema Heart & Health ETF's latest SEC N-PORT filing.
HRTS Prospectus and SEC Filings
Official Tema Heart & Health ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.